基因合成：各种技术与全球市场

全球基因合成市场规模预计将从2023年的20亿美元成长到2028年的41亿美元，预测期间内复合年增长率为15.8%。

抗体DNA合成领域预计将从2023年的12亿美元增加到2028年的25亿美元，同期复合年增长率为16.0%。病毒DNA合成产业预计将从2023年的5.266亿美元成长到2028年的11亿美元，复合年增长率为16.2%。

本报告调查了全球基因合成市场，并提供了市场概况、法律制度、市场影响因素和市场机会分析、市场规模趋势和预测、各个细分市场和地区的详细分析、竞争格局和主要企业市场机会。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场概况

第二章 市场概况

• 基因合成概述
• 基因合成方法
• 基因合成的应用
• 基因合成的科学进展
• 基因合成创新
• 基因合成的伦理考量
• 社会影响

第三章市场动态

• 概述
• 市场驱动因素
• 生物製药研究与开发
• 诊断和治疗应用
• 农业生物技术的进展
• DNA资料储存和合成基因组学
• 技术进步和成本降低
• 加大研发投入
• 个人化医疗的机会
• 抑制因素
• 成本限制
• 缺乏品管和标准化
• 机会
• 个人化医疗与精准医疗
• 基因合成中的人工智慧
• 任务
• 智慧财产权问题
• 处理时间长

第四章 监管状况

• 生物安全和双重用途问题
• 出口管制和贸易法规
• 智慧财产
• 临床应用的法律规范
• 道德和社会考虑
• 品质保证和产品标准
• 特定国家的监管挑战
• 美国
• 加拿大
• 欧洲
• 日本
• 印度
• 巴西

第五章新兴技术与发展

• 酶法 DNA 合成
• 微流体DNA合成
• 机器学习和人工智慧
• TBIO (Thermodynamically Balanced Inside-out)
• 基于连接酶的基因合成
• 基于聚合酵素的基因合成
• 专利分析

第六章市场区隔分析

• 细分细分
• 基因合成：全球市场
• 全球基因合成市场：依方法分类
• 固相合成
• 基于PCR的酶合成
• 基于晶片的合成
• 全球基因合成市场：依服务分类
• 抗体DNA合成
• 病毒DNA合成
• 其他的
• 全球基因合成市场：依应用分类
• 基因/细胞疗法的发展
• 疫苗开发
• 疾病诊断
• 其他的
• 全球基因合成市场：依最终用户分类
• 学术机构/政府研究机构
• 生物技术和製药公司
• CRO
• 地域分布
• 内部还是外包？
• 成本考虑
• 品管与保证
• 便利性和交货时间
• 客製化和专业化
• 战略考虑

第七章 竞争格局

• 公司排名
• 併购和创投
• 摘要

第8章附录

• 调查方法
• 来源
• 简称
• 公司简介
• AZENTA US INC.
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB BIOTECHNOLOGIES INC.
• PROTEOGENIX
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

The Antibody DNA synthesis market for Gene Synthesis is estimated to increase from $1.2 billion in 2023 to reach $2.5 billion by 2028, at a CAGR of 16.0% from 2023 through 2028.

The Viral DNA synthesis market for Gene Synthesis is estimated to increase from $526.6 million in 2023 to reach $1.1 billion by 2028, at a CAGR of 16.2% from 2023 through 2028.

Report Scope

This report explores critical trends in the gene synthesis market, including the market drivers and restraints, R&D spending, increasing competition, new technologies, product launches and therapeutic applications. Merger and acquisition (M&A) activity and partnerships between companies are also discussed. In this report, the global market for gene synthesis is segmented by method, services, application, end user and region. Companies considering expanding their geographic reach will find the coverage of the regional markets helpful.

Report Includes

• 26 data tables and 32 additional tables
• An analysis of the global markets for gene synthesis
• A discussion of the global market trends, with current and historical market revenue (sales figures) for 2021-2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
• An evaluation of the market size and revenue forecast for the global gene synthesis market, and corresponding market share analysis by method, services, application, end user and region
• A look at the drivers and challenges that affect the global market
• An analysis of the emerging technologies and new developments in the gene synthesis market
• A discussion of ESG developments, including consumer attitudes, impact of ESG on company performance, analysis of companies' ESG scores and the future of ESG, and ESG practices of leading companies
• An analysis of the vendor landscape, including the company market shares, recent M&A activity and the outlook for venture funding
• Company profiles of major players within the industry, including GenScript, Eurofins Scientific, Thermo Fisher Scientific Inc., Merck KGaA, and Azenta US Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview of Gene Synthesis
• Gene Synthesis Methods
• Gene Synthesis Applications
• Scientific Advances in Gene Synthesis
• Technological Innovation in Gene Synthesis
• Ethical Considerations in Gene Synthesis
• Societal Implications

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Biopharmaceutical R&D
• Diagnostic and Therapeutic Applications
• Advances in Agrobiotechnology
• DNA Data Storage and Synthetic Genomics
• Advances and Cost Reductions in Technology
• Rising Investments in R&D
• Opportunities in Personalized Medicine
• Restraints
• Cost Constraints
• Lack of Quality Control and Standardization
• Opportunities
• Personalized Medicine and Precision Healthcare
• AI in Gene Synthesis
• Challenges
• Intellectual Property Issues
• Long Turnaround Times

Chapter 4 Regulatory Landscape

• Biosecurity and Dual-use Concerns
• Export Controls and Trade Regulations
• Intellectual Property Rights
• Regulatory Oversight of Clinical Applications
• Ethical and Societal Considerations
• Quality Assurance and Product Standards
• Regulatory Challenges by Country
• United States
• Canada
• Europe
• Japan
• India
• Brazil

Chapter 5 Emerging Technologies and Developments

• Enzymatic DNA Synthesis
• Microfluidic DNA Synthesis
• Machine Learning and AI
• Thermodynamically Balanced Inside-out
• Ligase-based Gene Synthesis
• Polymerase-based Gene Synthesis
• Patent Analysis

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Gene Synthesis: Global Market
• Global Market for Gene Synthesis, by Method
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis
• Global Market for Gene Synthesis, by Services
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Other Gene Synthesis Services
• Gene Synthesis: Global Markets, by Application
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Other Applications
• Global Market for Gene Synthesis, by End User
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Geographic Breakdown
• In-house or Outsource?
• Cost Considerations
• Quality Control and Assurance
• Convenience and Turnaround Time
• Customization and Specialization
• Strategic Considerations

Chapter 7 Competitive Landscape

• Company Rankings
• M&A and Venture Funding
• In Summation

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• AZENTA US INC.
• DANAHER CORP.
• EUROFINS SCIENTIFIC
• GENSCRIPT
• MERCK KGAA
• ORIGENE TECHNOLOGIES INC.
• PROMAB BIOTECHNOLOGIES INC.
• PROTEOGENIX
• THERMO FISHER SCIENTIFIC INC.
• TWIST BIOSCIENCE

List of Tables

• Summary Table : Global Market for Gene Synthesis, by Services, Through 2028
• Table 1 : Patents Related to Gene Synthesis Market, by Owner, January 2023-March 2024
• Table 2 : Patents Related to Gene Synthesis Market, by Applicant, January 2023-March 2024
• Table 3 : Global Market for Gene Synthesis, Through 2028
• Table 4 : Global Market for Gene Synthesis, by Method, Through 2028
• Table 5 : Global Market for Solid-phase Synthesis, by Region, Through 2028
• Table 6 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
• Table 7 : Global Market for Chip-based Synthesis, by Region, Through 2028
• Table 8 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 9 : Global Market for Antibody DNA Synthesis, by Region, Through 2028
• Table 10 : Global Market for Viral DNA Synthesis, by Region, Through 2028
• Table 11 : Global Market for Other Synthesis Services, by Region, Through 2028
• Table 12 : Global Market for Gene Synthesis, by Application, Through 2028
• Table 13 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
• Table 14 : Global Market for Vaccine Development Applications, by Region, Through 2028
• Table 15 : Global Market for Disease Diagnosis Applications, by Region, Through 2028
• Table 16 : Global Market for Other Applications, by Region, Through 2028
• Table 17 : Global Market for Gene Synthesis, by End User, Through 2028
• Table 18 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
• Table 19 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
• Table 20 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
• Table 21 : Ranking of Gene Synthesis Companies, 2022
• Table 22 : Mergers and Acquisitions (M&A), 2021-2023
• Table 23 : Venture Funding, 2022 and 2023
• Table 24 : Report Sources
• Table 25 : Abbreviations Used in the Report
• Table 26 : Azenta US Inc.: Company Snapshot
• Table 27 : Azenta US Inc.: Financial Performance, FY 2022 and 2023
• Table 28 : Azenta US Inc.: Product Portfolio
• Table 29 : Azenta US Inc.: News/Key Developments, 2021-2023
• Table 30 : Danaher Corp.: Company Snapshot
• Table 31 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 32 : Danaher Corp.: Product Portfolio
• Table 33 : Danaher Corp.: News/Key Developments, 2023
• Table 34 : Eurofins Scientific: Company Snapshot
• Table 35 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
• Table 36 : Eurofins Scientific: Product Portfolio
• Table 37 : GenScript: Company Snapshot
• Table 38 : GenScript: Financial Performance, FY 2021 and 2022
• Table 39 : GenScript: Product Portfolio
• Table 40 : GenScript: News/Key Developments, 2023
• Table 41 : Merck KgaA: Company Snapshot
• Table 42 : Merck KgaA: Financial Performance, FY 2022 and 2023
• Table 43 : Merck KgaA: Product Portfolio
• Table 44 : Merck KgaA: News/Key Developments, 2022
• Table 45 : OriGene Technologies Inc.: Company Snapshot
• Table 46 : OriGene Technologies Inc.: Product Portfolio
• Table 47 : OriGene Technologies Inc.: News/Key Developments, 2022
• Table 48 : ProMab: Company Snapshot
• Table 49 : ProMab: Product Portfolio
• Table 50 : ProteoGenix: Company Snapshot
• Table 51 : ProteoGenix: Product Portfolio
• Table 52 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 53 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 54 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 55 : Twist Bioscience: Company Snapshot
• Table 56 : Twist Bioscience: Financial Performance, FY 2022 and 2023
• Table 57 : Twist Bioscience: Product Portfolio

List of Figures

• Summary Figure : Global Market for Gene Synthesis, by Services, 2020-2028
• Figure 1 : Market Dynamics of Gene Synthesis
• Figure 2 : Global Market Shares for Gene Synthesis, by Method, 2022
• Figure 3 : Global Market Shares for Gene Synthesis, by Services, 2022
• Figure 4 : Global Market Shares for Gene Synthesis, by Application, 2022
• Figure 5 : Global Market Shares for Gene Synthesis, by End User, 2022
• Figure 6 : Azenta US Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 7 : Azenta US Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 8 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 9 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
• Figure 10 : Eurofins Scientific: Revenue Shares, by Business Unit, FY 2023
• Figure 11 : Eurofins Scientific: Revenue Shares, by Country/Region, FY 2023
• Figure 12 : GenScript: Revenue Shares, by Business Unit, FY 2022
• Figure 13 : GenScript: Revenue Shares, by Country/Region, FY 2022
• Figure 14 : Merck KgaA: Revenue Shares, by Business Unit, FY 2023
• Figure 15 : Merck KgaA: Revenue Shares, by Country/Region, FY 2023
• Figure 16 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 17 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 18 : Twist Bioscience: Revenue Shares, by Business Unit, FY 2023
• Figure 19 : Twist Bioscience: Revenue Shares, by Country/Region, FY 2023